Innovus Pharma Signs Exclusive License and Distribution Agreement with BroadMed for EjectDelay in Lebanon
Innovus Pharmaceuticals, Inc. ("Innovus Pharma") (OTCMKTS:INNV), an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men and women's health and respiratory diseases today announced today that it has entered into an exclusive license and distribution agreement with BroadMedSAL, a Lebanese company ("BroadMed") under which Innovus Pharma granted to BroadMed an exclusive license to market and sell Innovus product EjectDelay® indicated for treatment of premature ejaculation in Lebanon. Under the...
View full press release